Latest News and Press Releases
Want to stay updated on the latest news?
-
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
Monte Rosa Therapeutics today reported business highlights and financial results for the first quarter ending March 31, 2024.
-
Monte Rosa Therapeutics Announces the Departure of Owen Wallace, Ph.D., Chief Scientific Officer
-
Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
-
Monte Rosa Therapeutics Announces Initiation of IND Enabling Studies for MRT-8102, A First-in-Class NEK7-Directed Molecular Glue Degrader
-
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
-
Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2024
-
Monte Rosa Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Monte Rosa Therapeutics to Present at Piper Sandler Healthcare Conference
-
Monte Rosa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
Monte Rosa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update